Pharma BD Deal Intelligence

Amgen Inc. / Onyx Pharmaceuticals

2013 · Acquisition/Merger · $10.4B · Complete

Announcement Sentiment

63

Positive

Outcome Score

67

Largely worked — most objectives met.

Amgen acquired Onyx Pharmaceuticals for $10.4B for cancer drug portfolio.

Key facts

Announced Aug 25, 2013
Closed Oct 01, 2013
Deal value $10.4B
Deal type Acquisition/Merger
Therapeutic area Oncology
Key assets Kyprolis

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals